blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0653205

EP0653205 - Non-chloroflurocarbon aerosol formulations [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  15.08.2008
Database last updated on 31.08.2024
Most recent event   Tooltip15.08.2008Revocation of patentpublished on 17.09.2008  [2008/38]
Applicant(s)For all designated states
Schering Corporation
2000 Galloping Hill Road
Kenilworth, NJ 07033-0530 / US
[N/P]
Former [1995/20]For all designated states
SCHERING CORPORATION
2000 Galloping Hill Road
Kenilworth, New Jersey 07033-0530 / US
Inventor(s)01 / Berry, Julianne
645 North Broadway, No. 13
Hastings-on-Hudson, New York 10706 / US
02 / Chaudry, Imtiaz A.
18 Rose Avenue
North Caldwell NY 07006 / US
03 / Sequeira, Joel A.
18 Stuyvesant Oval
New York NY 10009 / US
04 / Kopcha, Michael
141 Wycott Way West
East Brunswick NY 08816 / US
[1995/32]
Former [1995/20]01 / Fassberg, Julianne
175 W.12th Street
New York NY 10011 / US
02 / Chaudry, Imtiaz A.
18 Rose Avenue
North Caldwell NY 07006 / US
03 / Sequeira, Joel A.
18 Stuyvesant Oval
New York NY 10009 / US
04 / Kopcha, Michael
141 Wycott Way West
East Brunswick NY 08816 / US
Representative(s)Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
[N/P]
Former [2003/49]UEXKÜLL & STOLBERG
Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Former [1995/20]Schlich, George William, et al
Mathys & Squire 100 Grays Inn Road
London WC1X 8AL / GB
Application number, filing date95101762.308.06.1992
[1995/20]
Priority number, dateUS1991071278910.06.1991         Original published format: US 712789
[1995/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0653205
Date:17.05.1995
Language:EN
[1995/20]
Type: B1 Patent specification 
No.:EP0653205
Date:16.10.2002
Language:EN
[2002/42]
Search report(s)(Supplementary) European search report - dispatched on:EP30.03.1995
ClassificationIPC:A61K9/72, A61K31/58
[1995/20]
CPC:
A61K9/008 (EP,US); A61K31/573 (EP,US); A61K31/58 (EP,US);
A61K9/124 (EP,US); A61P11/06 (EP); C09K3/30 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1995/20]
TitleGerman:Fluorchlorkohlenwasserstofffreie Aerosolformulierungen[1995/20]
English:Non-chloroflurocarbon aerosol formulations[1995/20]
French:Formulations d'aérosols sans chlorofluorohydrocarbures[1995/20]
Examination procedure10.02.1995Examination requested  [1995/20]
14.06.1999Despatch of a communication from the examining division (Time limit: M06)
23.12.1999Reply to a communication from the examining division
16.02.2001Observations by third parties
23.03.2001Despatch of a communication from the examining division (Time limit: M06)
02.10.2001Reply to a communication from the examining division
19.02.2002Despatch of communication of intention to grant (Approval: Yes)
19.04.2002Communication of intention to grant the patent
23.07.2002Fee for grant paid
23.07.2002Fee for publishing/printing paid
Parent application(s)   TooltipEP92913922.8  / EP0587790
Divisional application(s)EP02022987.8  / EP1277467
EP06016402.7  / EP1736147
Opposition(s)Opponent(s)01  15.07.2003  24.07.2003  ADMISSIBLE
Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
IT-43100 Parma / IT
Opponent's representative
Schnappauf, Georg, et al, et al
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
 [N/P]
Former [2006/34]
Opponent(s)01  15.07.2003  24.07.2003  ADMISSIBLE
Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
IT-43100 Parma / IT
Opponent's representative
Schnappauf, Georg, et al, et al
Dr. Volker Vossius Patent- und Rechtsanwaltskanzlei Geibelstrasse 6
81679 München / DE
Former [2003/36]
Opponent(s)01  15.07.2003   
Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
IT-43100 Parma / IT
Opponent's representative
Grund, Martin, Dr., et al, et al
Dr. Volker Vossius Patent- & Rechtsanwaltskanzlei Geibelstrasse 6
81679 München / DE
21.08.2003Invitation to proprietor to file observations on the notice of opposition
30.04.2004Reply of patent proprietor to notice(s) of opposition
21.12.2004Date of oral proceedings
18.02.2005Despatch of interlocutory decision in opposition
18.02.2005Despatch of minutes of oral proceedings
21.02.2008Legal effect of revocation of patent [2008/38]
21.02.2008Despatch of communication that the patent will be revoked
Appeal following opposition14.04.2005Appeal received No.  T0501/05
17.06.2005Statement of grounds filed
21.02.2008Result of appeal procedure: revocation of the patent
21.02.2008Date of oral proceedings
Fees paidRenewal fee
10.02.1995Renewal fee patent year 03
15.05.1995Renewal fee patent year 04
15.05.1996Renewal fee patent year 05
13.05.1997Renewal fee patent year 06
20.05.1998Renewal fee patent year 07
25.05.1999Renewal fee patent year 08
22.05.2000Renewal fee patent year 09
17.08.2001Renewal fee patent year 10
07.06.2002Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
30.06.200110   M06   Fee paid on   17.08.2001
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT16.10.2002
BE16.10.2002
CH16.10.2002
GR16.10.2002
LI16.10.2002
NL16.10.2002
DK16.01.2003
PT16.01.2003
SE16.01.2003
LU08.06.2003
MC30.06.2003
[2007/16]
Former [2005/02]AT16.10.2002
BE16.10.2002
CH16.10.2002
GR16.10.2002
LI16.10.2002
NL16.10.2002
PT16.01.2003
SE16.01.2003
LU08.06.2003
MC30.06.2003
Former [2004/39]AT16.10.2002
BE16.10.2002
CH16.10.2002
GR16.10.2002
LI16.10.2002
NL16.10.2002
PT16.01.2003
SE16.01.2003
LU08.06.2003
Former [2003/51]AT16.10.2002
BE16.10.2002
CH16.10.2002
GR16.10.2002
LI16.10.2002
NL16.10.2002
PT16.01.2003
SE16.01.2003
Former [2003/39]AT16.10.2002
CH16.10.2002
GR16.10.2002
LI16.10.2002
NL16.10.2002
PT16.01.2003
SE16.01.2003
Former [2003/37]AT16.10.2002
GR16.10.2002
NL16.10.2002
PT16.01.2003
SE16.01.2003
Former [2003/31]GR16.10.2002
NL16.10.2002
PT16.01.2003
SE16.01.2003
Former [2003/30]NL16.10.2002
PT16.01.2003
SE16.01.2003
Former [2003/29]PT16.01.2003
SE16.01.2003
Former [2003/27]SE16.01.2003
Documents cited:Search[DY]EP0372777  (RIKER LABORATORIES INC [US]) [DY] 1-14 * the whole document * * page 2, line 4 - line 6 *;
 [DY]WO9104011  (RIKER LABORATORIES INC [US]) [DY] 1-14 * the whole document * * page 15, line 35 - line 40; example 2 *;
 [Y]  - The merck index, eleventh edition, RAHWAY, N.J. (US), MERCK & CO., INC., (1989), XP002135523 [Y] 1-14 * page 982, column 1; example 6151 *
 [Y]  - H. SAKONJO ET AL., "General pharmacological effects of mometasone furoate. II. Effects on EEG, respiration, and the cardiovascular system.", CHEMICAL ABSTRACTS, (19890911), vol. 111, no. 11, Database accession no. 90641W, page 104, column 1, XP002135524 [Y] 1-14 * abstract *
    [ ] - YONAGO IGAKU ZASSHI, JP, (1989), vol. 40, no. 3, pages 348 - 354
otherEP0057401
 EP0504112
    - "Medium Chain Triglycerides", HANDBOOK OF PHARMACEUTICAL EXCIPIENTS, vol. 3, pages 329 - 331
    - SCRIP, (1989), no. 1398, page 8
    - SCRIP, (1991), no. 1604, page 12
    - A REVIEW OF THE PATHOLOGY AND MANAGEMENT OF ASTHMA, PJB, (199102), pages 177 - 180
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.